James Parsons
Vermogen: 575 860 $ op 31-07-2026
Vermogen: 575 860 $ op 31-07-2026
Mr. James T.
Parsons, CPA, is a Chief Financial Officer & Director at Sernova Biotherapeutics, Inc. and a Chairman at DiaMedica Therapeutics, Inc. He is on the Board of Directors at Oncolytics Biotech, Inc. and Sernova Biotherapeutics, Inc. Mr. Parsons was previously employed as a Chief Financial & Accounting Officer by Trillium Therapeutics, Inc., a Chief Financial Officer by Amorfix Life Sciences Ltd., a Chief Financial Officer & Secretary by Trillium Therapeutics, Inc. /Old/, a Vice President-Finance & Administration by Lorus Therapeutics, Inc., and a Controller & Assistant Treasurer by Timminco Ltd. He also served on the board at YM BioSciences, Inc. He received his graduate degree from The University of Waterloo.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-06-2026 | 75.854 ( -.--% ) | 480 914 $ | 31-07-2026 | |
| 14-04-2026 | 614.605 ( 0,16% ) | 49 168 $ | 31-07-2026 | |
| 01-06-2026 | 41.849 ( 0,04% ) | 31 512 $ | 31-07-2026 | |
| 01-06-2026 | 2.250 ( 0% ) | 14 265 $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Voorzitter | 01-01-2025 |
| SERNOVA BIOTHERAPEUTICS INC | Financieel Directeur/CFO | 11-10-2024 |
| ONCOLYTICS BIOTECH INC. | Directeur/Bestuurslid | 16-06-2022 |
| Bedrijven | Functie | Einde |
|---|---|---|
| TRILLIUM THERAPEUTICS | Financieel Directeur/CFO | 17-11-2021 |
Trillium Therapeutics, Inc. /Old/
Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Provides research and development of pharmaceuticals | Financieel Directeur/CFO | 06-06-2014 |
| PROMIS NEUROSCIENCES, INC. | Financieel Directeur/CFO | 20-10-2010 |
| APTOSE BIOSCIENCES INC. | Financieel Directeur/CFO | 01-01-2003 |
| TIMMINCO LIMITED | Comptroller/Controller/Auditor | 01-01-2000 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 10 |
|---|---|
Aptose Biosciences, Inc.
Aptose Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, research and develops anticancer therapies with high safety profiles | Health Technology |
Oncolytics Biotech, Inc.
Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Produces cancer-related drug products | Health Technology |
Sernova Biotherapeutics, Inc.
Sernova Biotherapeutics, Inc. BiotechnologyHealth Technology Develops life science products | Health Technology |
Timminco Ltd.
Timminco Ltd. Metal FabricationProducer Manufacturing Manufactures specialty magnesium, calcium and strontium alloys | Producer Manufacturing |
Trillium Therapeutics, Inc.
Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
DiaMedica Therapeutics, Inc.
DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
ProMIS Neurosciences, Inc.
ProMIS Neurosciences, Inc. BiotechnologyHealth Technology Discovers and develops precision medicine solutions for the treatment of neurodegenerative & misfolded protein diseases | Health Technology |
The University of Waterloo
The University of Waterloo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trillium Therapeutics, Inc. /Old/
Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Provides research and development of pharmaceuticals | Commercial Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau